Year: 2020
Type: erratum
Abstract: “P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells.” Vayssade M, Haddada H, Faridoni-Laurens L, Tourpin S, Valent A, Bénard J, Ahomadegbe JC. Int J Cancer, 2005, 116(6):860-9; https://doi.org/10.1002/ijc.21033 An Erratum is issued in relation to the above article, published online on April 22, 2005 in Wiley InterScience (www.interscience.wiley.com) and in volume 116, pp. 860-869, by agreement between the authors, the journal Editor-in-Chief, Prof. Christoph Plass and John Wiley & Sons Ltd. The Erratum has been rendered due to concerns about the Western Blot in Figure 7. Through image integrity analysis it is presumed that individual bands in the left panel (MCF7/ADRIGR) of Figure 7, might have been improperly cut and pasted together in such a way that comparison to other bands, particular to controls, could be invalid: in the first row (Tap73α, ΔΝp73α), between the third and fourth lane and in the third row (GADD45), also between the third and fourth lane. The authors are unable to retrieve the original data due to the time that has elapsed but believe that the concerns do not affect the data interpretation and overall conclusion of the paper. Given that the experiments presented in this manuscript have been performed in 2004 or earlier and experimental and logistic conditions are very different now, the editors consider that a re-performance of the experiments would not be appropriate.
Source: International Journal of Cancer
DOI: 10.1002/ijc.33037
Language: French
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4237398984
